Details for New Drug Application (NDA): 213902
✉ Email this page to a colleague
The generic ingredient in FUROSEMIDE is furosemide. There are twenty-two drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for 213902
Tradename: | FUROSEMIDE |
Applicant: | Gland Pharma Ltd |
Ingredient: | furosemide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 213902
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 213902
Suppliers and Packaging for NDA: 213902
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 213902 | ANDA | Sagent Pharmaceuticals | 25021-311 | 25021-311-02 | 25 VIAL in 1 CARTON (25021-311-02) / 2 mL in 1 VIAL |
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 213902 | ANDA | Sagent Pharmaceuticals | 25021-311 | 25021-311-04 | 25 VIAL in 1 CARTON (25021-311-04) / 4 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Jul 1, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription